CB vs RNXT · P/E 14, rev $59.40B vs rev $266.0K
Chubb Ltd (CB) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CB and RNXT stock pages for the full models.
Not investment advice.